Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leverger

Showing results (251-260 of 434) with videos related to

Pageof 44
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric OncologyO Oberlin, G Leverger, H Pacquement, et al.
Blood|May 23, 2001
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemiaC Patte, A Auperin, J Michon, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2001
Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemiaR Bellott, A Auvrignon, T Leblanc, et al.
Journal of Pediatric Hematology/Oncology|April 9, 2008
SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational surveyYves Bertrand, Françoise Mechinaud, Benoit Brethon, et al.
Pediatric Blood & Cancer|November 9, 2010
CD34+ immunoselection of autologous grafts for the treatment of high-risk neuroblastomaAurélien Marabelle, Etienne Merlin, Pascale Halle, et al.
Journal of Pediatric Hematology/Oncology|August 13, 2005
Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in a cohort of French childrenBrigitte Bader-Meunier, Guy Leverger, Gil Tchernia, et al.
Cancer Causes & Control : CCC|January 26, 2002
Family cancer history and risk of childhood acute leukemia (France)F Perrillat, J Clavel, I Jaussent, et al.
Haematologica|March 1, 2015
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant studyAnne Jourdain, Anne Auperin, Véronique Minard-Colin, et al.
British Journal of Cancer|December 6, 2000
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)J Donadieu, M F Auclerc, A Baruchel, et al.
Pediatric Blood & Cancer|August 24, 2013
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 studyCyril Lervat, Anne Auperin, Catherine Patte, et al.
Pageof 44

Showing results (251-260 of 434) with videos related to

Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric OncologyO Oberlin, G Leverger, H Pacquement, et al.
Blood|May 23, 2001
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemiaC Patte, A Auperin, J Michon, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2001
Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemiaR Bellott, A Auvrignon, T Leblanc, et al.
Journal of Pediatric Hematology/Oncology|April 9, 2008
SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational surveyYves Bertrand, Françoise Mechinaud, Benoit Brethon, et al.
Pediatric Blood & Cancer|November 9, 2010
CD34+ immunoselection of autologous grafts for the treatment of high-risk neuroblastomaAurélien Marabelle, Etienne Merlin, Pascale Halle, et al.
Journal of Pediatric Hematology/Oncology|August 13, 2005
Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in a cohort of French childrenBrigitte Bader-Meunier, Guy Leverger, Gil Tchernia, et al.
Cancer Causes & Control : CCC|January 26, 2002
Family cancer history and risk of childhood acute leukemia (France)F Perrillat, J Clavel, I Jaussent, et al.
Haematologica|March 1, 2015
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant studyAnne Jourdain, Anne Auperin, Véronique Minard-Colin, et al.
British Journal of Cancer|December 6, 2000
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)J Donadieu, M F Auclerc, A Baruchel, et al.
Pediatric Blood & Cancer|August 24, 2013
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 studyCyril Lervat, Anne Auperin, Catherine Patte, et al.
Pageof 44